Biosimulation Market

Future Market Insights

Key Insight

The biosimulation market is projected to grow from USD 5.6 billion in 2025 to USD 39.3 billion by 2035, at a CAGR of 21.5%. Services will dominate with a 42.5% market share, while drug development will lead the deployment mode segment with a 47.0% share.

August 04, 2025

Anurag Sharma

250 Pages

Cite this Report

Biosimulation Market

https://www.futuremarketinsights.com/reports/biosimulation-market

License

Starting at US$ 5000

Buy Now

Summary ToC Companies

Key Players

Chemical Computing Group
Consulting Inc
Genedata AG
Insilico Biotechnology AG
Instem Group of Companies
Physiomics Plc
Rosa & Co. LLC
Simulation Plus Inc

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Biosimulation Market

Key Players

Similar Industry Reports